Riskpilot← Back to searchSign inGet full accessLjusberg Fysioterapi AB
ABActiveOrg 5592966013Johannesfredsvägen 64Physiotherapy activities · NACE 8695Est. 20211-4 employees
Revenue 2025
SEK 1,4M
+1% vs 2024
EBITDA margin
16.1%
+147% vs 2024
Equity ratio
57.3%
Financial strength
Net profit 2025
SEK 134K
+94% vs 2024
| Revenue | SEK 1,4M | +1% |
| EBITDA | SEK 223K | +147% |
| Net profit | SEK 134K | +94% |
| Total assets | SEK 278K | +24% |
| Equity | SEK 160K | +65% |
| Employees | — | — |
Legal name
Ljusberg Fysioterapi AB
Org number
5592966013
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
14 januari 2021
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Fysioterapi och därmed förenlig verksamhet inom human- och veterinärmedicin samt kattuppfödning.
Address
Johannesfredsvägen 64
Email
ann.ljus@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 100 | 1 360 | 1 223 | 1 368 | 1 384 |
| Staff expenses | — | −801 | −689 | −891 | −751 |
| EBITDA | −5 | 134 | 91 | 90 | 223 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −5 | 134 | 91 | 90 | 223 |
| Net financials | — | −3 | 0 | −2 | −3 |
| Profit before tax | −5 | 131 | 91 | 89 | 170 |
| Tax | −0 | −28 | −19 | −19 | −36 |
| Net profit | −5 | 104 | 72 | 69 | 134 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 116 | 194 | 226 | 224 | 278 |
| Equity | 20 | 124 | 98 | 97 | 160 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 95 | 70 | 128 | 128 | 69 |
| Total debt | 95 | 70 | 128 | 128 | 69 |
EBITDA margin
16.1%
This company
15.8%
Market median
+2% vs market
20212025
Equity ratio
57.3%
This company
38.2%
Market median
+50% vs market
20212025
Return on equity
84.0%
This company
18.4%
Market median
+357% vs market
20212025
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
20212025
Asset turnover
4.97×
This company
1.12×
Market median
+344% vs market
20212025
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ljusberg Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sabrina Caroline Laura Thams | Deputy Board Member | 0 companies |
| Patrik Carl Johannes Tavassoli | Board of Directors | 0 companies |
| Ann-Catrin Magdalena Ljusberg | Board of Directors | 0 companies |
| Jens Gunnar Rosenblad | Deputy Board Member | 0 companies |